77 related articles for article (PubMed ID: 10076783)
21. Effect of blood letting on serum aminotransferase levels of patients with chronic hepatitis C and iron overload.
Girelli CM; Mirata C; Casiraghi A
Recenti Prog Med; 1998 May; 89(5):241-4. PubMed ID: 9676130
[TBL] [Abstract][Full Text] [Related]
22. Amantadine therapy for chronic hepatitis C.
Smith JP; Riley TR; Devenyi A; Bingaman SI; Kunselman A
J Gen Intern Med; 2004 Jun; 19(6):662-8. PubMed ID: 15209605
[TBL] [Abstract][Full Text] [Related]
23. Early increased ficolin-2 concentrations are associated with severity of liver inflammation and efficacy of anti-viral therapy in chronic hepatitis C patients.
Hu YL; Luo FL; Fu JL; Chen TL; Wu SM; Zhou YD; Zhang XL
Scand J Immunol; 2013 Feb; 77(2):144-50. PubMed ID: 23298162
[TBL] [Abstract][Full Text] [Related]
24. Amantadine's viral kinetics in chronic hepatitis C infection.
Chan J; O'Riordan K; Wiley TE
Dig Dis Sci; 2002 Feb; 47(2):438-42. PubMed ID: 11855564
[TBL] [Abstract][Full Text] [Related]
25. Possible mechanisms of elevation of serum transaminase levels during interferon-beta therapy in chronic hepatitis C patients.
Fujimori K; Mochida S; Matsui A; Ohno A; Fujiwara K
J Gastroenterol; 2002 Jan; 37(1):40-6. PubMed ID: 11824799
[TBL] [Abstract][Full Text] [Related]
26. Treatment of chronic hepatitis C with amantadine.
Smith JP
Dig Dis Sci; 1997 Aug; 42(8):1681-7. PubMed ID: 9286234
[TBL] [Abstract][Full Text] [Related]
27. Interferon-alpha plus amantadine in chronic hepatitis C resistant to interferon alone: a pilot randomized study.
Gaeta GB; Stornaiuolo G; Stanzione M; Ascione T; Pasquazzi C; Taliani G; Cimino L; Budillon G; Piccinino F
J Viral Hepat; 2001 Jul; 8(4):284-6. PubMed ID: 11454180
[TBL] [Abstract][Full Text] [Related]
28. Treatment of chronic hepatitis C with amantadine.
Goff JS; Reveille RM; Johnson J
Dig Dis Sci; 2000 Jul; 45(7):1389-91. PubMed ID: 10961719
[TBL] [Abstract][Full Text] [Related]
29. Treatment of HCV positive individuals with normal serum ALT levels.
Van Thiel DH; Colantoni A; De Maria N
Hepatogastroenterology; 1998; 45(20):321-4. PubMed ID: 9638399
[TBL] [Abstract][Full Text] [Related]
30. Tauroursodeoxycholic acid for the treatment of HCV-related chronic hepatitis: a multicenter placebo-controlled study.
Crosignani A; Budillon G; Cimino L; Del Vecchio Blanco C; Loguercio C; Ideo G; Raimondo G; Stabilini R; Podda M
Hepatogastroenterology; 1998; 45(23):1624-9. PubMed ID: 9840118
[TBL] [Abstract][Full Text] [Related]
31. Preliminary results of ozone therapy as a possible treatment for patients with chronic hepatitis C.
Zaky S; Kamel SE; Hassan MS; Sallam NA; Shahata MA; Helal SR; Mahmoud H
J Altern Complement Med; 2011 Mar; 17(3):259-63. PubMed ID: 21417811
[TBL] [Abstract][Full Text] [Related]
32. Treatment of chronic hepatitis C patients with amantadine.
Yagura M; Harada H
J Gastroenterol; 2001 Nov; 36(11):759-63. PubMed ID: 11757748
[TBL] [Abstract][Full Text] [Related]
33. Antiviral activity of amantadine in elderly patients with chronic hepatitis C.
Torre F; Campo N; Giusto R; Ansaldi F; Icardi GC; Picciotto A
Gerontology; 2001; 47(6):330-3. PubMed ID: 11721147
[TBL] [Abstract][Full Text] [Related]
34. Amantadine for chronic hepatitis C: pilot study in 14 patients.
Andant C; Lamoril J; Deybach JC; Jouet P; Soulé JC
Eur J Gastroenterol Hepatol; 2000 Dec; 12(12):1319-22. PubMed ID: 11192321
[TBL] [Abstract][Full Text] [Related]
35. [Isoprinosine therapy in chronic hepatitis C (multicenter placebo-controlled double-blind prospective study)].
Pár A; Beró T; Brasch G; Gógl A; Kamarás G; Méhesfalvi E; Ozsvár Z; Paál M; Szipöcs I; Telegdy L
Orv Hetil; 1993 May; 134(19):1015-9. PubMed ID: 7684118
[TBL] [Abstract][Full Text] [Related]
36. Oral IDN-6556, an antiapoptotic caspase inhibitor, may lower aminotransferase activity in patients with chronic hepatitis C.
Pockros PJ; Schiff ER; Shiffman ML; McHutchison JG; Gish RG; Afdhal NH; Makhviladze M; Huyghe M; Hecht D; Oltersdorf T; Shapiro DA
Hepatology; 2007 Aug; 46(2):324-9. PubMed ID: 17654603
[TBL] [Abstract][Full Text] [Related]
37. [Amantadine--a new option in chronic hepatitis C?].
Eisenburg J
Fortschr Med; 1998 Feb; 116(5):40-1. PubMed ID: 9553304
[No Abstract] [Full Text] [Related]
38. Effects of simvastatin in patients with viral chronic hepatitis C.
Mihaila RG; Nedelcu L; Fratila O; Retzler L; Domnariu C; Cipaian RC; Rezi EC; Beca C; Deac M
Hepatogastroenterology; 2011; 58(109):1296-300. PubMed ID: 21937398
[TBL] [Abstract][Full Text] [Related]
39. Amantadine monotherapy of chronic hepatitis C patients infected with genotype lb.
Senturk H; Mert A; Akdogan M; Tabak F; Basaran G; Turkoglu S; Ozbay G; Badur S
Scand J Infect Dis; 2000; 32(5):575-6. PubMed ID: 11055673
[TBL] [Abstract][Full Text] [Related]
40. [Treatment of chronic hepatitis C by bicyclum, a randomized double-blind placebo controlled trial].
Yao G; Ji Y; Zhou X; Wang Q; Wu W
Zhonghua Yi Xue Za Zhi; 2002 Jul; 82(14):958-60. PubMed ID: 12181088
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
